: AN EMERGING TREATMENT OF ANEMIA IN CHRONIC KIDNEY DISEASE PATIENT ON HEMODAILYSIS
- Conditions
- Health Condition 1: N186- End stage renal disease
- Registration Number
- CTRI/2024/01/061462
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1)Ability to understand and given informed consent for participation
2)Male or female patients diagnosed with CKD Stage V
3)Aged =18 years at screening visit.
4)Patients on hemodialysis (=2 times in a week) for at least 12 weeks prior to screening visit and had access consisting of an arteriovenous fistula, AV graft, or permanent catheter).
5)Patients with no planned change in dialysis modality and with no planned renal transplant during study period
1)Red blood cell transfusion within 8 weeks prior to participating in the study.
2)Had history of previous or concurrent cancer.
3)Serologic status reflecting active hepatitis B or C infection or Human immunodeficiency virus (HIV) infection.
4)Active infection at initiation of study.
5)Had history of renal transplant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method